Fiduciary Trust Co Boosts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Fiduciary Trust Co increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 69,090 shares of the healthcare conglomerate’s stock after acquiring an additional 496 shares during the period. Fiduciary Trust Co’s holdings in UnitedHealth Group were worth $40,396,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Delta Financial Group Inc. raised its position in UnitedHealth Group by 1.0% in the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after acquiring an additional 17 shares during the period. Signature Resources Capital Management LLC lifted its position in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 18 shares in the last quarter. Saxony Capital Management LLC increased its position in UnitedHealth Group by 3.5% in the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after buying an additional 18 shares in the last quarter. GoalVest Advisory LLC lifted its position in shares of UnitedHealth Group by 0.6% during the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after buying an additional 18 shares in the last quarter. Finally, Fiduciary Group LLC increased its holdings in UnitedHealth Group by 0.5% in the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after acquiring an additional 18 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have weighed in on UNH. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, November 20th. Bank of America lowered their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Stephens decreased their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Truist Financial reaffirmed a “buy” rating and set a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Finally, UBS Group cut their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $618.26.

UnitedHealth Group Price Performance

UNH opened at $608.38 on Thursday. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The business has a fifty day moving average of $584.09 and a 200 day moving average of $555.02. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock has a market cap of $559.88 billion, a P/E ratio of 39.63, a PEG ratio of 1.78 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the firm posted $6.56 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.38%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.